Fluocinolone acetonide intravitreal implant for diabetic macular edema: A 3-year multicenter, randomized, controlled clinical trial

Ophthalmology

Volumn 118, Issue 8, 2011, Pages 1580-1587

  Pearson, P Andrew ^a   Comstock, Timothy L ^b   Ip, Michael ^c   Callanan, David ^d   Morse, Lawrence S ^e   Ashton, Paul ^f   Levy, Brian ^b   Mann, Eric S ^g   Eliott, Dean ^h  

^a UNIVERSITY OF KENTUCKY   (United States)

^b BAUSCH AND LOMB   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d TEXAS RETINA ASSOCIATES   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f pSiMedica Ltd   (United Kingdom)

^g Retina Group Ltd   (United States)

^h HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOCINOLONE ACETONIDE; INSULIN;

ABNORMAL SENSATION; ANEMIA; ARTICLE; BLURRED VISION; CATARACT; CORONARY ARTERY DISEASE; DEVICE REMOVAL; DIABETES MELLITUS; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DISEASE SEVERITY; DRUG EFFICACY; DRUG IMPLANT; DRUG SAFETY; EYE IRRITATION; EYE PAIN; FILTERING OPERATION; FLUORESCENCE ANGIOGRAPHY; GLUCOSE BLOOD LEVEL; HEADACHE; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; LACRIMATION; LASER; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OBSERVATION; PHOTOPHOBIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RETINA MACULA EDEMA; SCORING SYSTEM; SIDE EFFECT; SINGLE BLIND PROCEDURE; STEROID THERAPY; SUSTAINED DRUG RELEASE; TREATMENT OUTCOME; VISUAL ACUITY; VITREOUS HEMORRHAGE;

CATARACT; DIABETIC RETINOPATHY; DOUBLE-BLIND METHOD; DRUG IMPLANTS; FEMALE; FLUOCINOLONE ACETONIDE; FLUORESCEIN ANGIOGRAPHY; GLUCOCORTICOIDS; HUMANS; INTRAOCULAR PRESSURE; MACULAR EDEMA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; RETINA; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VISUAL ACUITY; VITREOUS BODY;

EID: 79961044911     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2011.02.048     Document Type: Article

References (28)

1. L.P. Aiello The potential role of PKC beta in diabetic retinopathy and macular edema Surv Ophthalmol 47 suppl 2 2002 S263 S269
2. T.W. Gardner, B. Sander, and M.L. Larsen An extension of the Early Treatment Diabetic Retinopathy Study (ETDRS) system for grading of diabetic macular edema in the Astemizole Retinopathy Trial Curr Eye Res 31 2006 535 547 (Pubitemid 43884600)
3. A. Martidis, J.S. Duker, and P.B. Greenberg Intravitreal triamcinolone for refractory diabetic macular edema Ophthalmology 109 2002 920 927 (Pubitemid 34465226)
4. P.G. Tranos, F. Topouzis, and N.T. Stangos Effect of laser photocoagulation treatment for diabetic macular oedema on patient's vision-related quality of life Curr Eye Res 29 2004 41 49 (Pubitemid 39389440)
5. ETDRS Photocoagulation for diabetic macular edema Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group Arch Ophthalmol 103 1985 1796 1806
6. M.V. Emerson, and A.K. Lauer Emerging therapies for the treatment of neovascular age-related macular degeneration and diabetic macular edema BioDrugs 21 2007 245 257 (Pubitemid 47104980)
7. Diabetic Retinopathy Clinical Research Network A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema Ophthalmology 115 2008 1447 1449
8. Diabetic Retinopathy Clinical Research Network A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema Ophthalmology 114 2007 1860 1867
9. J.F. Arevalo, J. Fromow-Guerra, and H. Quiroz-Mercado Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up Ophthalmology 114 2007 743 750 (Pubitemid 46483714)
10. D.W. Chun, J.S. Heier, and T.M. Topping A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema Ophthalmology 113 2006 1706 1712 (Pubitemid 44442451)
11. E.T. Cunningham Jr., A.P. Adamis, and M. Altaweel A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema Ophthalmology 112 2005 1747 1757
12. S. Fraser-Bell, A. Kaines, and P.G. Hykin Update on treatments for diabetic macular edema Curr Opin Ophthalmol 19 2008 185 189 (Pubitemid 351535912)
13. C. Haritoglou, D. Kook, and A. Neubauer Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema Retina 26 2006 999 1005 (Pubitemid 44973218)
14. S.J. Bakri, A. Shah, N.S. Falk, and P.M. Beer Intravitreal preservative-free triamcinolone acetonide for the treatment of macular oedema Eye 19 2005 686 688 (Pubitemid 40895485)
15. R.D. Jager, L.P. Aiello, S.C. Patel, and E.T. Cunningham Jr Risks of intravitreous injection: a comprehensive review Retina 24 2004 676 698 (Pubitemid 39391758)
16. D.G. Callanan, G.J. Jaffe, and D.F. Martin Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results Arch Ophthalmol 126 2008 1191 1201
17. G.J. Jaffe, D. Martin, and D. Callanan Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study Ophthalmology 113 2006 1020 1027 (Pubitemid 43795240)
18. G.J. Jaffe, C.H. Yang, and H. Guo Safety and pharmacokinetics of an intraocular fluocinolone acetonide sustained delivery device Invest Ophthalmol Vis Sci 41 2000 3569 3575
19. M. Shahidi, Y. Ogura, N.P. Blair, and R. Zeimer Retinal thickness change after focal laser treatment of diabetic macular oedema Br J Ophthalmol 78 1994 827 830 (Pubitemid 24345946)
20. G.J. Jaffe, R.M. McCallum, and B. Branchaud Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis Ophthalmology 112 2005 1192 1198
21. Retisert prescribing information April 2005 Bausch & Lomb, Inc. Rochester, NY
22. F. Patelli, G. Fasolino, and P. Radice Time course of changes in retinal thickness and visual acuity after intravitreal triamcinolone acetonide for diffuse diabetic macular edema with and without previous macular laser treatment Retina 25 2005 840 845 (Pubitemid 41456573)
23. B.E. Klein, R. Klein, and S.E. Moss Change in visual acuity associated with cataract surgery The Beaver Dam Eye Study Ophthalmology 103 1996 1727 1731 (Pubitemid 26403721)
24. N. Bandi, and U.B. Kompella Budesonide reduces vascular endothelial growth factor secretion and expression in airway (Calu-1) and alveolar (A549) epithelial cells Eur J Pharmacol 425 2001 109 116 (Pubitemid 32739155)
25. M.D. Becker, J.R. Smith, R. Max, and C. Fiehn Management of sight-threatening uveitis: new therapeutic options Drugs 65 2005 497 519 (Pubitemid 40469554)
26. N.M. Holekamp, M.A. Thomas, and A. Pearson The safety profile of long-term, high-dose intraocular corticosteroid delivery Am J Ophthalmol 139 2005 421 428 (Pubitemid 40379067)
27. M.C. Gillies, M. Kuzniarz, and J. Craig Intravitreal triamcinolone- induced elevated intraocular pressure is associated with the development of posterior subcapsular cataract Ophthalmology 112 2005 139 143 (Pubitemid 40075333)
28. T. Yilmaz, C. Weaver, and M. Gallagher Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review Ophthalmology 116 2009 902 911